Shares of GENinCode Plc (LON:GENI – Get Free Report) traded up 2.4% during mid-day trading on Wednesday . The company traded as high as GBX 6.92 ($0.09) and last traded at GBX 6.91 ($0.09). 312,000 shares were traded during trading, an increase of 18% from the average session volume of 264,771 shares. The stock had previously closed at GBX 6.75 ($0.09).
GENinCode Stock Performance
The company has a market capitalization of £12.23 million, a price-to-earnings ratio of -115.22 and a beta of 0.62. The firm has a fifty day simple moving average of GBX 7.49 and a 200 day simple moving average of GBX 6.09. The company has a debt-to-equity ratio of 6.74, a current ratio of 5.92 and a quick ratio of 15.89.
About GENinCode
GENinCode Plc develops and commercializes clinical genetic tests to provide predictive analysis of risk to a patient's health based on their genes in the United Kingdom and internationally. Its predictive technology provides patients and physicians with preventative care and treatment strategies.
Recommended Stories
- Five stocks we like better than GENinCode
- Where to Find Earnings Call Transcripts
- AbbVie Stock: A Perfect Dip for Investors to Buy
- Investing in Construction Stocks
- Forget NVIDIA: Super Micro Computer Stock Leads in Momentum
- Stock Splits, Do They Really Impact Investors?
- GitLab Stock Rebounds: The Inside Story of Its Comeback
Receive News & Ratings for GENinCode Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GENinCode and related companies with MarketBeat.com's FREE daily email newsletter.
